Mikra Successfully Launches Serenity, an Innovative Mental Health Product for Anxiety
November 30, 2023 07:00 ET
|
Lifeist Wellness Inc.
TORONTO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in...
Lucy Scientific Discovery’s Alternative Mental Health Treatments to Provide Opportunity to Improve Mental Health
October 18, 2023 07:00 ET
|
Lucy Scientific Discovery Inc.
From herbal remedies to psychedelics, like psilocybin and MDMA, Lucy Scientific is working to provide the ingredients for groundbreaking mental health ther
Intermountain Healthcare Researchers Find Most Commonly Prescribed Class of Anti-Depressant Medications Do Not Reduce COVID Severity
November 09, 2022 09:00 ET
|
Intermountain Healthcare
Salt Lake City, UT, Nov. 09, 2022 (GLOBE NEWSWIRE) -- A new study by researchers at Intermountain Healthcare in Salt Lake City finds that the most commonly prescribed class of anti-depressants does...
Depression Drugs Global Market Report 2022: Emergence of Novel Techniques for the Development of Antidepressants With Minimal Side-Effects Presents Opportunities
October 13, 2022 07:58 ET
|
Research and Markets
Dublin, Oct. 13, 2022 (GLOBE NEWSWIRE) -- The "Depression Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Global Depression Treatment Therapy Market Report 2022-2028: Selective Serotonin Reuptake Inhibitors (SSRIs) Hold Significant Share
October 10, 2022 06:43 ET
|
Research and Markets
Dublin, Oct. 10, 2022 (GLOBE NEWSWIRE) -- The "Global Depression Treatment Therapy Market Research and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global...
Enterin Announces Publication of Exciting Discoveries About the Enterin Nervous System
November 19, 2021 09:00 ET
|
Enterin Inc.
PHILADELPHIA, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Enterin Inc., a privately held Philadelphia-based clinical-stage biopharmaceutical company pioneering novel treatments for neurodegenerative and...
DEPRESSION PATENT FOR OROTATE APPROVED & GRANTED BY US PATENT OFFICE
October 11, 2021 10:40 ET
|
Medlab Clinical Ltd
SYDNEY, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Medlab Clinical LTD (ASX:MDC) is pleased to announce the Orotate patent, specifically to addressing depression in United States of America has been granted....
Worldwide Depression Treatment Industry to 2026 - Increasing Awareness About Mental Illness is Accelerating Market Growth
August 05, 2021 07:58 ET
|
Research and Markets
Dublin, Aug. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Depression Treatment Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The rising prevalence of depression among the...
Global Depression Drugs Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
June 25, 2021 07:48 ET
|
Research and Markets
Dublin, June 25, 2021 (GLOBE NEWSWIRE) -- The "Depression Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Global Post-Traumatic Stress Disorder Therapeutics Market Report 2021-2029: Stage, Age-Specific, Products, End Users and Geography
June 16, 2021 07:03 ET
|
Research and Markets
Dublin, June 16, 2021 (GLOBE NEWSWIRE) -- The "Post-Traumatic Stress Disorder Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...